[Primary adenocarcinoma of the bladder as single tumor. Study of 7 cases and review of the literature]. 1990

A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
Servico de Urología del Hospital Ramón y Cajal de Madrid.

Primary vesical adenocarcinoma is an extremely uncommon tumour, representing 0.5 to 2% of all the urothelial vesical neoplasias. Its behaviour is aggressive and its prognosis poor, especially in the seal ring cell variety. We present our experience in seven cases of vesical adenocarcinoma: one of urachal origin, two of the seal ring cell type, and four of the urothelial type with no other specificity. All were advanced stage tumours at diagnosis. There is no unified therapeutic strategy, and poor results were obtained with the various treatments used. Survival eight months after diagnosis was 42.8%. Longest survival is 15 months, corresponding to the adenocarcinoma of urachal origin.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
January 1987, Archivos espanoles de urologia,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
December 2016, Annales de pathologie,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
September 1991, British journal of urology,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
March 1991, Archivos espanoles de urologia,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
April 2015, The Indian journal of surgery,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
January 1996, Annales de chirurgie,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
April 1983, Urology,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
September 2014, Archivos espanoles de urologia,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
September 2020, Indian journal of surgical oncology,
A Fernández Fernández, and E Maganto Pavón, and J Vallejo Herrador, and A Escudero Barrilero
May 1977, Archives of surgery (Chicago, Ill. : 1960),
Copied contents to your clipboard!